Related Experiment Video
Updated: May 1, 2026

Original Experimental Approach for Assessing Transport Fuel Stability
Published on: October 21, 2016
In-use stability modeling
Robert T Magari1, Elena Afonina
1Beckman Coulter, Inc., 11800 SW 147 Ave., Miami, FL 33196-2500, USA. Robert.Magari@beckman.com
Abstract:
Experimental design and modeling of in-use stability testing are presented in this paper. In-use open container degradation is considered in terms of time open container or/and the number of instances that the same container is used. Degradation is estimated based on two models, the fixed and the general model. The fixed model estimates in-use degradation for those fixed time points of closed container where the in-used experimental data is collected. The general model estimates in-use degradation for any time point of closed container using the estimated relationship between closed container time and the degradation rate of open container. Data for in-use open container stability does not have to be collected at a closed container time of interest to estimate in-use degradation at this time point as long as this point is within the range of the experiment. Stability of the product in terms of drift from the initial time to the time of interest is calculated as the sum of closed and in-use open containers drifts.
Related Concept Videos
Stability of Equilibrium Configuration
A stable equilibrium occurs when a system tends to return to its original position when given a small displacement, and the potential energy is at its minimum. An example of a stable equilibrium is when a cantilever beam is fixed at one end and a weight is attached to the other end. If the weight...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
In Vitro Drug Dissolution: Compendial Testing Models I
Drug Product Stability
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

